Top News

Genzum Raises $20M For Generic Pharmaceuticals Effort

Los Angeles-based biopharmaceuticals firm Genzum has raised $20M in a funding round, according to backer SG LLC. According to SG, its Alternative Investments Division invested $20M in Genzum, to go towards that company's expansion of its pipeline of generic pharmaceutical products. Genzum develops, commercializes, and licenses generic pharmaceutical products, and is led by Chris Achar. More information »


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel